References
- Alkhateeb AA, Han B, Connor JR (2013). Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages. Breast Cancer Res Treat, 137, 733-44. https://doi.org/10.1007/s10549-012-2405-x
- Berry DA, Cronin KA, Plevritis SK, et al (2005). Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med, 353, 1784-92. https://doi.org/10.1056/NEJMoa050518
- Blake-Mortimer JS, Sephton SE, Carlson RW, Stites D, Spiegel D (2004). Cytotoxic T lymphocyte count and survival time in women with metastatic breast cancer. Breast J, 10, 195-9. https://doi.org/10.1111/j.1075-122X.2004.21290.x
- Cho Y, Miyamoto M, Kato K, et al (2003). CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma. Cancer Res, 63, 1555-9.
- Curigliano G, Spitaleri G, Dettori M, et al (2007). Vaccine immunotherapy in breast cancer treatment: Promising, but still early. Expert Rev Anticancer Ther, 7, 1225-41. https://doi.org/10.1586/14737140.7.9.1225
- Domschke C, Schuetz F, Ge Y, et al (2009) Intratumoral cytokines and tumor cell biology determine spontaneous breast cancerspecific immune responses and their correlation to prognosis. Cancer Res, 69, 8420-28. https://doi.org/10.1158/0008-5472.CAN-09-1627
- Effros RB (2004). Replicative senescence of CD8+ T cells: potential effects on cancer immune surveillance and immunotherapy. Cancer Immunol Immunother, 53, 925-33.
- Emens LA, Reilly RT, Jaffee EM (2004). Augmenting the potency of breast cancer vaccines: Combined modality immunotherapy. Breast Dis, 20, 13-24. https://doi.org/10.3233/BD-2004-20103
- Fehervari Z, Sakaguchi S (2004). CD4+ Tregs and immune control. J Clin Invest, 114, 1209-17. https://doi.org/10.1172/JCI200423395
- Gokmen NM, Gokmen E (2011). Analysis of lymphocyte subtypes by flow cytometry after adjuvant chemotherapy for early-stage breast cancer. Ege J Med, 50, 33-8.
- Hinkel A, Tso CL, Gitlitz BJ, et al (2000). Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma. J Immunother, 23, 83-93. https://doi.org/10.1097/00002371-200001000-00011
- Kagi D, Ledermann B, Burki K (1994). Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature, 369, 31-7. https://doi.org/10.1038/369031a0
- Kagi D, Ledermann B, Burki K (1996). Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol, 14, 207-32. https://doi.org/10.1146/annurev.immunol.14.1.207
- Leong PP, Mohammad R, Ibrahim N, et al (2006). Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast. Immunol Lett, 102, 229-36 https://doi.org/10.1016/j.imlet.2005.09.006
- Liang J, Wang C, Chang K (1993). Circulating intercellular adhesion molecule-1 and lymphocyte subsets involved in immune response of breast cancer. Sheng Wu Chi Mien Hsuen Tsa Chih, 26, 1-5.
- Matsuura K, Yamaguchi Y, Ueno H, et al (2006). Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma. Cancer, 106, 1227-36. https://doi.org/10.1002/cncr.21729
- Melichar B, Touskova M, Dvorak J, et al (2001). Peripheral blood leukocyte phenotype in patients with breast cancer: Effect of doxorubicin/paclitaxel combination chemotherapy. Immunopharmacol Immunotoxicol, 23, 163-73. https://doi.org/10.1081/IPH-100103857
- Rakha EA, El-Sayed ME, Lee AH, et al (2008). Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. J Clin Oncol, 26, 3153-58. https://doi.org/10.1200/JCO.2007.15.5986
- Rey-Ferro M, Castano R, Orozco O, Serna A, Moreno A (1997). Nutritional and immunologic evaluation of patients with gastric cancer before and after surgery. Nutrition, 13, 878-81. https://doi.org/10.1016/S0899-9007(97)00269-4
- Scheuring UJ, Sabzevari H, Theofilopoulos AN (2002). Proliferative arrest and cell cycle regulation in CD8+CD28− versus CD8+CD28+ T cells. Hum Immunol, 63, 1000-9. https://doi.org/10.1016/S0198-8859(02)00683-3
- Schmidt M, Bohm D, von Torne C, et al (2008). The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res, 68, 5405-13. https://doi.org/10.1158/0008-5472.CAN-07-5206
- Schwartz GF, Hughes KS, Lynch HT, et al (2008). Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management. Cancer, 113, 2627-37. https://doi.org/10.1002/cncr.23903
- Shen Y, Qu QX, Zhu YB, et al (2012). Analysis of Cd8+Cd28-T-suppressor cells in gastric cancer patients. J Immunoassay and Immunochem, 33, 149-55. https://doi.org/10.1080/15321819.2011.609575
- Shu S, Plautz G, Krauss J (1997). Tumor immunology. JAMA, 278, 1972-81. https://doi.org/10.1001/jama.1997.03550220178023
- Siegel R, Ward E, Brawley O, et al (2011). Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 61, 212. https://doi.org/10.3322/caac.20121
- Simpson PT, Reis-Filho JS, Gale T, Lakhani SR (2005). Molecular evolution of breast cancer. J Pathol, 205, 248-54. https://doi.org/10.1002/path.1691
- Van der Hage JA, Mieog JS, van de Velde CJ, et al (2011). Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trials. Breast Cancer Res, 13, 68. https://doi.org/10.1186/bcr2908
- Wang YX, Ruan CP, Li L, Shi JH, Kong XT (1999). Clinical significance of changes of perioperative T cell and expression of its activatedantigen in colorectal cancer patients. World J Gastroenterol, 5, 181-2. https://doi.org/10.3748/wjg.v5.i2.181
Cited by
- Lack of Prognostic Value of Blood Parameters in Patients Receiving Adjuvant Radiotherapy for Breast Cancer vol.15, pp.10, 2014, https://doi.org/10.7314/APJCP.2014.15.10.4225
- Relationship of Body Mass Index with Prognosis in Breast Cancer Patients Treated with Adjuvant Radiotherapy and Chemotherapy vol.15, pp.10, 2014, https://doi.org/10.7314/APJCP.2014.15.10.4233
- F-FDG SPECT with Serum Procalcitonin for Identification of Etiology in Tumor Patients with Fever of Unknown Origin vol.15, pp.2, 2014, https://doi.org/10.7314/APJCP.2014.15.2.683
- Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy pp.1699-3055, 2018, https://doi.org/10.1007/s12094-017-1732-0